PFWD Related Analyst Ratings
-
Phase Forward (PFWD) Higher On UBS Upgrade
-
UBS Upgrades Phase Forward (PFWD) to Buy
-
Citi Initiates Coverage on Phase Forward (PFWD) with a Neutral
-
Piper Jaffray Downgrades Phase Forward (PFWD) to Neutral; Lack of Near-Term Catalysts
-
Leerink Swann Resumed Healthcare Technology and Distribution Sector With Positive Bias
-
Emerging Growth Equities Upgrades Phase Forward (PFWD) to Buy
-
Raymond James Downgrades Phase Forward (PFWD) to Outperform
-
Dougherty Initiates Coverage on Phase Forward (PFWD) with a Buy
-
Needham Upgrades Phase Forward (PFWD) to Buy
-
Friedman Billings Upgrades Phase Forward (PFWD) to Outperform
-
Matrix USA Rating Changes 4/2
-
Brean Murray upgrades Phase Forward (PFWD) to Buy
-
Raymond James Upgrades Phase Forward (PFWD) to Strong Buy
-
Brean Murray downgrades Phase Forward (PFWD) to Hold
-
UBS Initiates Coverage on Phase Forward (PFWD) with a Neutral
-
Matrix USA Rating Changes 11/12
-
Matrix USA Rating Changes 10/2
-
Pacific Crest Initiates Coverage on Phase Forward (PFWD) with an Outperform
-
Brean Murray Upgrades Phase Forward Inc. (PFWD) to Buy
-
Raymond James downgrades Phase Forward (PFWD) to Market Perform
-
Jefferies & Co Initiates Coverage on Phase Forward (PFWD) with a Buy
-
Piper Jaffray upgrades Phase Forward (PFWD) to Outperform
-
Needham downgrades KNXA, CAPA, PFWD - Bloomberg
-
Ferris Baker Watts downgrades Phase Forward (PFWD) to Neutral
-
Friedman Billings Downgrades Phase Forward (PFWD) to Market Perform
-
Needham Starts PFWD at Strong Buy - Bloomberg
-
Friedman Billings Starts PFWD at Outperform
Back to PFWD Stock Lookup
